Get notified when SCNX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Departure Of Cfo (new) — The Chief Financial Officer resigned from the company effective May 26, 2026.
NASDAQ: SCNX Scienture Holdings, Inc. 8-K

Scienture CFO Eric Sherb resigns; Co-CEO Dr. Mani assumes interim financial role

Filed May 29, 2026 · Period ending May 26, 2026 · ~1 min read

Key Changes

  • high

    CFO Eric Sherb resigned effective May 26, 2026, citing personal reasons with no dispute with management or the board.

    Item 5.02 verify on EDGAR →
  • high

    Co-CEO Dr. Narasimhan Mani appointed Interim CFO while retaining his existing executive roles as Co-CEO and President.

    Item 5.02 verify on EDGAR →
  • medium

    Dr. Mani brings 25+ years pharmaceutical experience, prior financial leadership roles at life sciences companies, and an MBA in Finance from Columbia Business School.

    Item 5.02 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (ADMT 10-K) is open in full — no account needed.

Partner

Trade SCNX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Source-verified from EDGAR · Narrative written by AI · May 29, 2026 · How we verify